Annual Current Liabilities
$4.95 M
+$824.70 K+19.99%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual total current liabilities is $4.95 million, with the most recent change of +$824.70 thousand (+19.99%) on December 31, 2023.
- During the last 3 years, GANX annual current liabilities has risen by +$2.84 million (+134.06%).
- GANX annual current liabilities is now at all-time high.
Performance
GANX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.59 M
-$1.93 M-29.56%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly total current liabilities is $4.59 million, with the most recent change of -$1.93 million (-29.56%) on September 30, 2024.
- Over the past year, GANX quarterly current liabilities has dropped by -$355.20 thousand (-7.18%).
- GANX quarterly current liabilities is now -29.56% below its all-time high of $6.52 million, reached on June 30, 2024.
Performance
GANX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GANX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.0% | -7.2% |
| 3 y3 years | +134.1% | +80.0% |
| 5 y5 years | - | +80.0% |
GANX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.9% | -29.6% | +80.0% |
| 5 y | 5-year | at high | +463.1% | -29.6% | +117.3% |
| alltime | all time | at high | +463.1% | -29.6% | +117.3% |
Gain Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.59 M(-29.6%) |
| Jun 2024 | - | $6.52 M(+30.4%) |
| Mar 2024 | - | $5.00 M(+1.1%) |
| Dec 2023 | $4.95 M(+20.0%) | $4.95 M(-14.1%) |
| Sep 2023 | - | $5.76 M(+3.1%) |
| Jun 2023 | - | $5.59 M(+8.4%) |
| Mar 2023 | - | $5.16 M(+25.0%) |
| Dec 2022 | $4.13 M | $4.13 M(-4.8%) |
| Sep 2022 | - | $4.33 M(+27.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $3.41 M(-19.1%) |
| Mar 2022 | - | $4.22 M(+65.2%) |
| Dec 2021 | $2.55 M(+20.7%) | - |
| Dec 2021 | - | $2.55 M(-28.6%) |
| Sep 2021 | - | $3.58 M(+45.9%) |
| Jun 2021 | - | $2.45 M(+5.3%) |
| Mar 2021 | - | $2.33 M(+10.0%) |
| Dec 2020 | $2.11 M(+140.6%) | - |
| Dec 2020 | - | $2.11 M |
| Dec 2019 | $879.10 K | - |
FAQ
- What is Gain Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Gain Therapeutics?
- What is Gain Therapeutics annual current liabilities year-on-year change?
- What is Gain Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Gain Therapeutics?
- What is Gain Therapeutics quarterly current liabilities year-on-year change?
What is Gain Therapeutics annual total current liabilities?
The current annual current liabilities of GANX is $4.95 M
What is the all time high annual current liabilities for Gain Therapeutics?
Gain Therapeutics all-time high annual total current liabilities is $4.95 M
What is Gain Therapeutics annual current liabilities year-on-year change?
Over the past year, GANX annual total current liabilities has changed by +$824.70 K (+19.99%)
What is Gain Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of GANX is $4.59 M
What is the all time high quarterly current liabilities for Gain Therapeutics?
Gain Therapeutics all-time high quarterly total current liabilities is $6.52 M
What is Gain Therapeutics quarterly current liabilities year-on-year change?
Over the past year, GANX quarterly total current liabilities has changed by -$355.20 K (-7.18%)